BOOK
Phototherapy And Photodiagnostic Methods For The Practitioner
Chong Wei Sheng | Pan Jiun Yit | Tan Eugene Sern Ting
(2017)
Additional Information
Book Details
Abstract
Phototherapy, or the usage of light to treat diseases, is an important modality in a physician's therapeutic armamentarium. It is effective for a number of common skin conditions like atopic dermatitis, psoriasis and vitiligo. The accurate diagnosis of a photodermatosis or light-related skin disorder relies on a good clinical history and physical examination, supported by diagnostic investigations such as phototesting.Phototherapy and Photodiagnostic Methods for the Practitioner is the first published set of practical guidelines for Asian skin, drawing upon our cumulative clinical experience with phototherapy for various conditions at the National Skin Centre in Singapore, amalgamated with up-to-date evidence from the scientific literature. It is designed to serve as a concise and comprehensive reference manual for dermatologists, as well as clinicians, medical physicists and nurses with an interest in photodiagnostic investigations and phototherapy for the evaluation and treatment of skin disorders.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Contents | v | ||
| Editors | vii | ||
| Contributors | ix | ||
| Forewords | xi | ||
| Foreword | xiii | ||
| Preface | xv | ||
| Chapter 1 Introduction to Phototherapy | 1 | ||
| Chapter 2 Nursing Considerations in Phototherapy | 3 | ||
| Pre-Phototherapy Advice | 3 | ||
| NBUVB Treatment Procedure | 4 | ||
| Oral PUVA Treatment Procedure | 5 | ||
| Bath/Soak/Paint PUVA Treatment Procedure | 7 | ||
| Chapter 3 Narrowband Ultraviolet B Phototherapy | 9 | ||
| Background | 9 | ||
| Indications of NBUVB Phototherapy | 10 | ||
| Contraindications to NBUVB Phototherapy | 11 | ||
| Treatment Regimen and Dosimetry | 12 | ||
| Retinoid-NBUVB (Re-NBUVB) Treatment Regimen and Dosimetry [C, IV] | 17 | ||
| Skin Cancer Surveillance for Patients on Long-Term NBUVB Phototherapy [C, IV] | 17 | ||
| Further Reading | 18 | ||
| Chapter 4 Combined Ultraviolet A/Narrowband Ultraviolet B Phototherapy | 19 | ||
| Background | 19 | ||
| Indications of Combined UVA/NBUVB Phototherapy | 20 | ||
| Contraindications to Combined UVA/NBUVB Phototherapy | 21 | ||
| Adverse Effects of Combined UVA/NBUVB Phototherapy | 21 | ||
| Treatment Regimen and Dosimetry | 22 | ||
| Further Reading | 25 | ||
| Chapter 5 Psoralen-Ultraviolet A Photochemotherapy | 27 | ||
| Background | 27 | ||
| PUVA Modalities: Practical Aspects | 28 | ||
| Indications of PUVA Photochemotherapy | 32 | ||
| Contraindications to PUVA Photochemotherapy | 32 | ||
| Adverse Effects of PUVA Photochemotherapy | 33 | ||
| Screening and Monitoring (Oral PUVA Photochemotherapy) | 34 | ||
| Treatment Regimen and Dosimetry | 34 | ||
| Retinoid-PUVA (Re-PUVA) Treatment Regimen and Dosimetry [C, IV] | 41 | ||
| Skin Cancer Surveillance for Patients on Long-Term PUVA Photochemotherapy [C, IV] | 42 | ||
| Further Reading | 42 | ||
| Chapter 6 Ultraviolet A-1 Phototherapy | 45 | ||
| Background | 45 | ||
| Delivery of UVA-1 | 45 | ||
| Indications of UVA-1 Phototherapy | 47 | ||
| Contraindications to UVA-1 Phototherapy | 47 | ||
| Adverse Effects of UVA-1 Phototherapy | 48 | ||
| Dosimetry Regimens | 48 | ||
| Skin Cancer Surveillance for Patients on Long-Term UVA-1 Phototherapy [C, IV] | 50 | ||
| Further Reading | 51 | ||
| Chapter 7 Excimer Light Phototherapy | 53 | ||
| Background | 53 | ||
| Excimer Light | 54 | ||
| Indications of Excimer Light Phototherapy [B, IIA] | 55 | ||
| Contraindications to Excimer Light Phototherapy | 56 | ||
| Adverse Effects of Excimer Light Phototherapy | 56 | ||
| Psoriasis Protocol [C, IV] | 57 | ||
| Vitiligo Protocol [C, IV] | 59 | ||
| Treatment of Specific Dermatoses | 62 | ||
| Further Reading | 64 | ||
| Chapter 8 Photodynamic Therapy | 65 | ||
| Background | 65 | ||
| Indications of PDT | 67 | ||
| Contraindications to PDT | 67 | ||
| Adverse Effects of PDT | 67 | ||
| Treatment Procedure | 68 | ||
| Summary of Treatment Evidence for the Main Indications | 70 | ||
| Further Reading | 71 | ||
| Chapter 9 Phototesting | 73 | ||
| Background | 73 | ||
| Indications of Phototesting | 73 | ||
| General Principles in Phototesting | 74 | ||
| Therapeutic Phototesting Procedure for NBUVB Phototherapy and PUVA Photochemotherapy [C, IV] | 77 | ||
| NBUVB Test Site Reactions | 79 | ||
| Oral PUVA Test Site Reactions | 79 | ||
| Bath PUVA Test Site Reactions | 80 | ||
| Diagnostic Phototesting Procedure for UVA and UVB [C, IV] | 80 | ||
| UVA and UVB Test Site Reactions | 82 | ||
| Diagnostic Phototesting Procedure for VIS [C, IV] | 83 | ||
| Important Note on Solar Urticaria | 84 | ||
| Normal Ranges of MED-UVA and MED-UVB [C, IV] | 85 | ||
| Expected Phototesting Responses in Common Photodermatoses | 85 | ||
| Further Reading | 86 | ||
| Chapter 10 Photopatch Testing | 87 | ||
| Background | 87 | ||
| Indications of Photopatch Testing | 87 | ||
| Patient Preparation | 88 | ||
| Procedure for Photopatch Testing [B, IIb] | 89 | ||
| Interpretation of Results | 92 | ||
| Documentation of Clinical Relevance | 93 | ||
| Complications | 93 | ||
| Photopatch Testing in UVA-Sensitive Individuals [C, IV] | 94 | ||
| Further Reading | 95 | ||
| Chapter 11 Photoprovocation Testing | 97 | ||
| Background | 97 | ||
| Indications of Photoprovocation Testing | 97 | ||
| Patient Preparation | 98 | ||
| Procedure for Photoprovocation Testing [C, IV] | 98 | ||
| Systemic Drug Photochallenge [C, IV] | 101 | ||
| Interpretation of Readings | 102 | ||
| Complications | 103 | ||
| Further Reading | 103 | ||
| Annexes | 105 | ||
| Annex A Minimal Erythema Dose Testing Dosimetry | 105 | ||
| Annex B Minimal Phototoxic Dose Testing Dosimetry | 109 | ||
| Annex C Photopatch Testing Series | 111 | ||
| Annex D Evidence Grading for Recommendations | 115 | ||
| Index | 117 |